Delivery Order SPE2DB22D1106-SPE2DB24FFJV3

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $37,505.17 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565321162 LIDOCAINE 5% PATCH 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $1,001.41 to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565320971 - LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities, including...
The U.S. Defense Logistics Agency (DLA) awarded a $4,075.79 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4565733878 - LIDOCAINE 5% PATCH 30S, with a performance period ending on September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,850.57 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565879217 - LIDOCAINE 5% PATCH 30S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,239.62 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565678797 ! LIDOCAINE 5% PATCH 30S. This delivery order was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a $1,109.75 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA) for the supply of 4565735143 - LIDOCAINE 5% PATCH 30S. The delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,232.19 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564054998 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,168.77 firm fixed-price contract is for the supply of 4565667882 - LIDOCAINE 5% PATCH 30S, with a period of performance through September 4, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. government awarded a delivery order contract worth $1,034.40 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 4565673717 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565334211 - LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $2,492.76 and is a Firm Fixed Price contract type. It is not set aside for any special designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFJV3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,186.46 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4565597607 - LIDOCAINE 5% PATCH 30S. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 28, 2024 and does not utilize a set-aside designation.

Generated 11/26/24, 9:34 AM